Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis

Medical Mycology

Volumn 51, Issue 8, 2013, Pages 811-817

  Jhun, Byung Woo ^a   Jeon, Kyeongman ^a   Eom, Jung Seop ^a   Lee, Ji Hyun ^a   Suh, Gee Young ^a   Kwon, O Jung ^a   Koh, Won Jung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Aspergillosis; Itraconazole; Nontuberculous mycobacteria; Treatment outcome

Indexed keywords

ITRACONAZOLE; VORICONAZOLE;

ADULT; AGED; ANOREXIA; ANTIMICROBIAL THERAPY; ARTICLE; ATYPICAL MYCOBACTERIUM; CHRONIC LUNG DISEASE; CHRONIC PULMONARY ASPERGILLOSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEATH; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; GENERALIZED EDEMA; HUMAN; INFECTION RISK; LABORATORY TEST; LIVER TOXICITY; LUNG ASPERGILLOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MYCETOMA; NAUSEA; PLEURA THICKENING; QT PROLONGATION; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE;

CORYNEBACTERINEAE;

ADMINISTRATION, ORAL; AGED; ANTIFUNGAL AGENTS; CHRONIC DISEASE; FEMALE; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS; PULMONARY ASPERGILLOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84885915920     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2013.806826     Document Type: Article

References (25)

1. Walsh TJ, Anaissie EJ, Denning DW, et al . Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society of America . Clin Infect Dis 2008 ; 46: 327-360
2. Vaid M, Kaur S, Sambatakou H, et al . D istinct alleles of mannosebinding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis . Clin Chem Lab Med 2007 ; 45: 183-186
3. Smith NL, Denning DW . Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma . Eur Respir J 2011 ; 37: 865-872
4. Ohba H, Miwa S, Shirai M, et al . Clinical characteristics and prognosis of chronic pulmonary aspergillosis . Respir Med 2012 ; 106: 724-729
5. Izumikawa K, Yamamoto Y, Mihara T, et al . Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis. Med Mycol 2012 ; 50: 811-817
6. Cadranel J, Philippe B, Hennequin C, et al . Voriconazole for chronic pulmonary aspergillosis: A prospective multicenter trial . Eur J Clin Microbiol Infect Dis 2012 ; 31: 3231-3239
7. Camuset J, Nunes H, Dombret MC, et al . Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients . Chest 2007 ; 131: 1435-1441
8. Nam HS, Jeon K, Um SW, et al . C linical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: A review of 43 cases . Int J Inf Dis 2010 ; 14: E479-482
9. Denning DW, Riniotis K, Dobrashian R, Sambatakou H . Chronic cavitary and fi brosing pulmonary and pleural aspergillosis: Case series, proposed nomenclature change, and review . Clin Inf Dis 2003 ; 37 (Suppl. 3): S265-280
10. Zmeili OS, Soubani AO . Pulmonary aspergillosis: A clinical update. QJM 2007 ; 100: 317-334
11. Kohno S, Masaoka T, Yamaguchi H, et al . A multicenter, openlabel clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan . Scand J Infect Dis 2004 ; 36: 372-379
12. Park SY, Lee SO, Choi SH, et al . Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma. Clin Infect Dis 2011 ; 52: E149-152
13. Jeon K, Kwon OJ, Lee NY, et al . Antibiotic treatment of M ycobacterium abscessus lung disease: A retrospective analysis of 65 patients. Am J Respir Crit Care Med 2009 ; 180: 896-902
14. Koh WJ, Jeon K, Lee NY, et al . Clinical signifi cance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus . Am J Respir Crit Care Med 2011 ; 183: 405-410
15. De Beule K, De Doncker P, Cauwenbergh G, et al . The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987) . Mycoses 1988 ; 31: 476-485
16. Dupont B . Itraconazole therapy in aspergillosis: Study in 49 patients. J Am Acad Dermatol 1990 ; 23: 607-614
17. Caras WE, Pluss JL . Chronic necrotizing pulmonary aspergillosis: Pathologic outcome after itraconazole therapy . Mayo Clin Proc 1996; 71: 25-30
18. Elliott JA, Milne LJ, Cumming D . Chronic necrotising pulmonary aspergillosis treated with itraconazole . Thorax 1989 ; 44: 820-821
19. Campbell JH, Winter JH, Richardson MD, Shankland GS, Banham SW . Treatment of pulmonary aspergilloma with itraconazole. Thorax 1991 ; 46: 839-841
20. Yoshida K, Kurashima A, Kamei K, et al . Efficacy and safety of shortand long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study . J Inf Chemother 2012 ; 18: 378-385
21. Soubani AO, Chandrasekar PH . The clinical spectrum of pulmonary aspergillosis . Chest 2002 ; 121: 1988-1999
22. Kobashi Y, Fukuda M, Yoshida K, et al . C hronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease . Respirology 2006 ; 11: 809-813
23. Koh WJ, Yu CM, Suh GY, et al . Pulmonary TB and NTM lung disease: Comparison of characteristics in patients with AFB smearpositive sputum . Int J Tuberc Lung Dis 2006 ; 10: 1001-1007
24. Griffi th DE, Aksamit T, Brown-Elliott BA, et al . An offi cial ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases . Am J Respir Crit Care Med 2007 ; 175: 367-416
25. Tucker RM, Denning DW, Hanson LH, et al . Interaction of azoles with rifampin, phenytoin, and carbamazepine: In vitro and clinical observations . Clin Infect Dis 1992 ; 14: 165-174